EGFR/ARF6 regulation of Hh signalling stimulates oncogenic Ras tumour overgrowth
EGFR signalling is required for oncogenic Ras driven tumorigenesis. In this study, using aDrosophilatumour model the authors demonstrate that depletion of Arf6, a Ras-related GTP-binding protein activated by EGFR, supresses oncogenic Ras driven overgrowth via modulation of Hedgehog signalling.
Guardado en:
Autores principales: | Chiswili Chabu, Da-Ming Li, Tian Xu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/22505722246448f89a425539c5692e26 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cooperation between oncogenic Ras and wild-type p53 stimulates STAT non-cell autonomously to promote tumor radioresistance
por: Yong-Li Dong, et al.
Publicado: (2021) -
Discovery of a dual Ras and ARF6 inhibitor from a GPCR endocytosis screen
por: Jenna Giubilaro, et al.
Publicado: (2021) -
EGFRAP encodes a new negative regulator of the EGFR acting in both normal and oncogenic EGFR/Ras-driven tissue morphogenesis.
por: Jennifer Soler Beatty, et al.
Publicado: (2021) -
Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration
por: Seung-Min Shin, et al.
Publicado: (2017) -
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
por: Beth O. Van Emburgh, et al.
Publicado: (2016)